Role of antioxidants in the nitric oxide-elicited inhibition of dopamine uptake in cultured mesencephalic neurons. Insights into potential mechanisms of nitric oxide-mediated neurotoxicity

Neurochemistry International

Volumn 28, Issue 5-6, 1996, Pages 609-617

  Cook, John A ^a   Wink, David A ^a   Blount, Vincent ^a   Krishna, Murali C ^a   Hanbauer, Ingeborg ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIOXIDANT; ASCORBIC ACID; DOPAMINE; GLUTATHIONE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; SEMIQUINONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOPAMINE UPTAKE; DOSE RESPONSE; ELECTROCHEMISTRY; EMBRYO; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MESENCEPHALON; NERVE CELL CULTURE; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALIA;

EID: 0030008445     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-0186(95)00125-5     Document Type: Article

References (27)

1. Beckman J. S., Smith C. M. and Koppenol W. H. (1993) ALS, SOD, and peroxynitrite. Nature 364, 584.
2. Dawson V. L., Dawson T. M., London E. D., Bredt D. S. and Snyder S. H. (1991) Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. natn. Acad. Sci. U.S.A. 88, 6368-6371.
3. deErausquin G., Costa E. and Hanbauer I. (1994) Calcium homeostasis, free radical formation, and trophic factor dependence mechanisms in Parkinson's disease. Pharmac. Rev. 46, 467-482.
4. Garthwaite J., Charles S. L. and Chess-Williams R. (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336, 385-388.
5. Gibson A., Babbedge R., Brave S. R., Hart S. L., Hobbs A. J., Tucker J. F., Wallace P. and Moore P. K. (1992) An investigation of some S-nitrosothiols, and of hydroxyarginine, on the mouse anococcygeus. Br. J. Pharmac. 107, 715-721.
6. 3H]cocaine recognition sites in primary cultures of mesencephalic neurons during in vitro development. J. Neurochem. 56, 2108-2115.
7. Guevara-Guzman R., Emson P. C. and Kendrick K. M. (1994) Modulation of in vivo striatal transmitter release by nitric oxide and cyclic GMP. J. Neurochem. 62, 807-810.
8. 3H]dopamine from striatal slices. NeuroReport 3, 409-412.
9. Hanbauer I., Cox G. W. and Wink D. A. (1994) Synaptic and extrasynaptic action of free radicals on cell-to-cell signaling. Ann. N. Y. Acad. Sci. 738, 173-180.
10. Hogg N., Kalyanarama B., Joseph J., Struck A. and Parthasarathy S. (1993) Inhibition of low-density lipoprotein oxidation by nitric oxide. Potential role in atherogenesis. FEBS Lett. 334, 170-174.
11. Kalyanaraman B., Felix C. C. and Sealy R. C. (1985) Semiquinone anion radicals of catechol(amine)s, catechol estrogens, and their metal ion complexes. Environ. Health Perspec. 64, 185-198.
12. Kanner J., Harel S. and Granit R. (1991) Nitric oxide as an antioxidant. Arch. Biochem. Biophys. 289, 130-136.
13. Kanner J., Harel S. and Granit R. (1992) Nitric oxide, an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids 27, 46-49.
14. Michel P. P. and Hefti F. (1990) Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture. J. Neurosci. Res. 26, 428-435.
15. Moncada S., Palmer R. M. J. and Higgs E. A. (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmac. Rev. 43, 109-142.
16. Montague P. R., Cancayco C. D., Winn M. J., Marchase R. B. and Friedlander M. J. (1994) Role of NO production in NMDA receptor-mediated neurotransmitter release in cerebral cortex. Science 263, 973-977.
17. Morley D., Maragos C. M., Zhang X. Y., Boignon M., Wink D. A. and Keefer L. K. (1993) Mechanism of vascular relaxation induced by nitric oxide (NO)/nucleophile complexes, a new class of NO-based vasodilators. J. Cardiovasc. Pharmac. 21, 670-676.
18. 3H]GBR-12935 binding proteins. Arch. Biochem. Biophys. 276, 424-432.
19. 3H]dopamine uptake. Brain Res. 641, 83-91.
20. Rikans L. E. and Moore D. R. (1988) Effect of aging on aqueous-phase antioxidants in tissue of male Fischer rats. Biochim. biophys. Acta 966, 269-275.
21. Singal P. K., Kapur N., Dhillon K. S., Beamish R. E. and Dhalla N. S. (1982) Role of free radicals in catecholamine-induced cardiomyopathy. Can. J. Pharmac. 60, 1390-1397.
22. 3H]WIN 35,428 binding, a marker for dopamine transporter, in embryonic mesencephalic neuronal cultures with striatal membranes of adult rats. J. Neurochem. 60, 469-416.
23. Wink D. A., Hanbauer I., Krishna M. C., DeGraff W., Gamson J. and Mitchell J. B. (1993a) Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. natn. Acad. Sci. U.S.A. 90, 9813-9817.
24. Wink D. A., Darbyshire J. F., Nims R. W., Saveedra J. E. and Ford P. C. (1993b) Reactions of the bioregulatory agent nitric oxide in oxygenated aqueous media: determination of the kinetics for oxidation and nitrosation by intermediates generated in the NO/O2 reaction. Chem. Res. Toxic. 6, 23-27.
25. Wink D. A., Osawa Y., Darbyshire J. F., Jones C. R., Eshenaur S. C. and Nims R. W. (1993c) Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch. Biochem. Biophys. 300, 115-123.
26. Wink D. A., Nims R. W., Darbyshire J. F., Christodoulou D., Hanbauer I., Cox G. W., Laval F., Laval J., Cook J. A., Krishna M. C., DeGraff W. and Mitchell J. B. (1994) Reaction kinetics for nitrosation of cysteine and glutathione in aerobic nitric oxide solutions at neutral pH. Insights into the fate and physiological effects of intermediates generated in the NO/O2 reaction. Chem. Res. Toxic. 7, 519-525.
27. Wink D. A., Cook J. A., Krishna M., Hanbauer I., DeGraff W., Gamson J. and Mitchell J. (1995) Nitric oxide protects against alkyl peroxide mediated cytotoxicity. Insights into the role nitric oxide plays in lipid peroxidation. Arch. Biochem. Biophys. 319, 402-407.